Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03112369 · ClinicalTrials.gov registry record · NA
Preventing HIV Among Native Americans Through the Treatment PTSD & Substance Use
A NA study of HIV Prevention and PTSD and Substance Use Disorder, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT03112369: Completed NA study of HIV Prevention and PTSD and Substance Use Disorder, sponsored by University of Washington.
NCT03112369 is a NA study of HIV Prevention and PTSD and Substance Use Disorder that has completed, run by University of Washington. The registered enrollment target is 125 participants, below the 378-participant average among 32 other HIV Prevention trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03112369, a NA study of HIV Prevention and PTSD and Substance Use Disorder, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will conduct a two-arm, comparative effectiveness randomized controlled trial of two culturally adapted, empirically based programs (EBP) - Narrative Exposure Therapy (NET) vs. Motivational Interviewing with Skills Training (MIST) in terms of lowering HIV sexual-risk behaviors (HSB) for American Indian / Alaska Native (AIAN) men and women. NET addresses Posttraumatic Stress Disorder (PTSD) as a pathway to preventing substance use disorders (SUD) and HSB whereas MIST addresses substance misuse as a way of preventing SUD and HSB.
Primary Outcome
Measuring change in high risk sexual behavior for contracting HIV.
Conditions Studied
Interventions
- BEHAVIORAL Narrative Exposure Therapy (NET)
- BEHAVIORAL Motivational Interviewing w/Skills Training (MIST)
Study Locations (1)
Washington
- University of Washington School of Social Work - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2017-09-21 |
| Est. Completion | 2024-08-30 |
| Phase | NA |
What the finished NCT03112369 record still lists
NCT03112369 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 378-participant average among 32 other HIV Prevention trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with HIV Prevention appearing as the primary indexed condition, and to 2 interventions - of which Narrative Exposure Therapy (NET) is the first listed.
NCT03112369 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT03112369 about?
NCT03112369 is a clinical study titled "Preventing HIV Among Native Americans Through the Treatment PTSD & Substance Use". Investigators will conduct a two-arm, comparative effectiveness randomized controlled trial of two culturally adapted, empirically based programs (EBP) - Narrative Exposure Therapy (NET) vs. Motivational Interviewing with Skills Training (MIST) in terms of lowering HIV sexual-risk behaviors (HSB) fo...
What is the current status of trial NCT03112369?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2017-09-21. Estimated completion is 2024-08-30.
What conditions does trial NCT03112369 study?
This clinical trial studies the following conditions: HIV Prevention, PTSD and Substance Use Disorder.
What interventions are being tested in trial NCT03112369?
The interventions under investigation include: Narrative Exposure Therapy (NET) (BEHAVIORAL), Motivational Interviewing w/Skills Training (MIST) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03112369?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03112369 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03112369's enrollment target sits among peer trials
125 16th of 32 higher than 17 of 32 other HIV Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using PrEP, Doing It for Ourselves
RECRUITING · NA
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
RECRUITING · NA
-
Intervention to Enhance PrEP Persistence
RECRUITING · NA
-
WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
RECRUITING · NA
-
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI